SecBot SecBot
SECBOTREPLAY Home › Report › IINN

IINN · Inspira Technologies received a $580,000 commercial purchase order from…

Inspira Technologies · PRESS-RELEASE filed May 18, 2026 at 07:30 ET

At the news

BULLISHIMPACT 5/10

PRESS-RELEASE filed May 18, 2026 at 07:30 ET

Inspira Technologies received a $580,000 commercial purchase order from NYU Langone Hospital for its FDA-cleared ART100 blood circulation systems, following a multi-patient clinical evaluation. The order provides a key reference for ongoing strategic discussions to monetize the ART100 platform and medical assets.

  • $580,000 commercial purchase order from NYU Langone Hospital for ART100 systems
  • Order follows successful clinical evaluation in over 30 patients
  • NYU Langone is a top-ranked academic medical center; provides strong reference for commercial discussions
  • Company is engaged in an active strategic process to potentially monetize the ART100 platform and other medical assets

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access